Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Bast

Showing results (251-260 of 299) with videos related to

Pageof 30
Sort By:
Progress in Clinical and Biological Research|January 1, 1990
Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantationE J Shpall, I C Anderson, R C Bast, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical OncologyR C Bast, P Ravdin, D F Hayes, et al.
Nature|August 18, 1994
Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitorG M McGeehan, J D Becherer, R C Bast, et al.
American Journal of Obstetrics and Gynecology|April 1, 1990
Heterogeneity of antigen expression in advanced epithelial ovarian cancerA Berchuck, G J Olt, A P Soisson, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 11, 1992
p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistryB J Kerns, P A Jordan, M B Moore, et al.
Oncogene|December 17, 1997
Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibitionH J Xu, Y Zhou, W Ji, et al.
Gynecologic Oncology|March 1, 1990
Prospective evaluation of serum CA 125 levels in a normal population, phase I: the specificities of single and serial determinations in testing for ovarian cancerV R Zurawski, K Sjovall, D A Schoenfeld, et al.
International Journal of Cancer|February 1, 1993
Antibody-induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185F Xu, R Lupu, G C Rodriguez, et al.
Cancer Research|September 1, 1987
Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complementA Haleem, J Kurtzberg, G A Olsen, et al.
Journal of the National Cancer Institute|September 15, 1993
Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancerM F Kohler, J R Marks, R W Wiseman, et al.
Pageof 30

Showing results (251-260 of 299) with videos related to

Sort By:
Pageof 30
Progress in Clinical and Biological Research|January 1, 1990
Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantationE J Shpall, I C Anderson, R C Bast, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical OncologyR C Bast, P Ravdin, D F Hayes, et al.
Nature|August 18, 1994
Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitorG M McGeehan, J D Becherer, R C Bast, et al.
American Journal of Obstetrics and Gynecology|April 1, 1990
Heterogeneity of antigen expression in advanced epithelial ovarian cancerA Berchuck, G J Olt, A P Soisson, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 11, 1992
p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistryB J Kerns, P A Jordan, M B Moore, et al.
Oncogene|December 17, 1997
Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibitionH J Xu, Y Zhou, W Ji, et al.
Gynecologic Oncology|March 1, 1990
Prospective evaluation of serum CA 125 levels in a normal population, phase I: the specificities of single and serial determinations in testing for ovarian cancerV R Zurawski, K Sjovall, D A Schoenfeld, et al.
International Journal of Cancer|February 1, 1993
Antibody-induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185F Xu, R Lupu, G C Rodriguez, et al.
Cancer Research|September 1, 1987
Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complementA Haleem, J Kurtzberg, G A Olsen, et al.
Journal of the National Cancer Institute|September 15, 1993
Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancerM F Kohler, J R Marks, R W Wiseman, et al.
Pageof 30